Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area

Journal of Neuroscience

Volumn 25, Issue 25, 2005, Pages 6005-6015

  McClung, Colleen A ^a   Nestler, Eric J ^a   Zachariou, Venetia ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

DNA microarray; Dopaminergic; Drug abuse; Dynorphin; FKBP5; Noradrenergic; Opiate addiction and withdrawal

Indexed keywords

FK 506 BINDING PROTEIN; GALANIN; MORPHINE; PRODYNORPHIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DNA MICROARRAY; DOPAMINERGIC NERVE CELL; DRUG DEPENDENCE; DRUG WITHDRAWAL; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; LOCOMOTION; LOCUS CERULEUS; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VENTRAL TEGMENTUM;

ACTINS; ANIMALS; GENE EXPRESSION REGULATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; LOCUS COERULEUS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SUBSTANCE WITHDRAWAL SYNDROME; VENTRAL TEGMENTAL AREA;

EID: 21344468365     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0062-05.2005     Document Type: Article

References (52)

1. Aghajanian GK (1978) Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 276:186-188.
2. Aghajanian GK, Wang YY (1986) Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons. Brain Res 371:390-394.
3. Ahmadi-Abhari SA, Akhondzadeh S, Assadi SM, Shabestari OL, Farzanehgan ZM, Kamlipour A (2001) Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial. J Clin Pharm Ther 26:67-71.
4. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, Grandy DK, Williams JT (2002) μ-Opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22:5769-5776.
5. Ammon S, Mayer P, Riechert U, Tischmeyer H, Hollt V (2003) Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res Mol Brain Res 112:113-125.
6. Beitner-Johnson D, Nestler EJ (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57:344-347.
7. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300.
8. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Kunzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, et al (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Gen 36:1319-1325.
9. Bonci A, Williams JT (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16:631-639.
10. Bonci A, Williams JT (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796-803.
11. Boundy VA, Gold SJ, Messer CJ, Chen J, Son JH, Joh TH, Nestler EJ (1998) Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. J Neurosci 18:9989-9995.
12. Corness JD, Burbach JP, Hokfelt T (1997) The rat galanin-gene promoter: response to members of the nuclear hormone receptor family, phorbol ester and forskolin. Brain Res Mol Brain Res 47:11-23.
13. Cui CL, Wu LZ, Han JS (2000) Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat. Neurosci Lett 295:45-48.
14. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ (1996) Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16:274-282.
15. Florianczyk B, Stryjecka-Zimmer M (2001) Induction of metallothioneins by ethanol and morphine. Ann Univ Mariae Curie Sklodowska [Med] 56:183-187.
16. Georges F, Stinus L, Bloch B, Le Moine C (1999) Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neursci 11:481-490.
17. Gold SJ, Han MH, Herman AE, Ni YG, Pudiak CM, Aghajanian GK, Liu RJ, Potts BW, Mumby SM, Nestler EJ (2003) Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur J Neurosci 17:971-980.
18. Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ (1992) Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 58:1168-1171.
19. Harris GC, Williams JT (1991) Transient homologous mu-opioid receptor desensitization in rat locus coeruleus neurons. J Neurosci 11:2574-2581.
20. Hidalgo J, Giralt M, Garvey JS, Armario A (1991) Effect of morphine administration on rat liver metallothionein and zinc metabolism. J Pharmacol Exp Ther 259:274-278.
21. Homayoun H, Khavandgar S, Mehr S, Ejtemaei S, Namiranian K, Dehpour AR (2003) The effects of FK506 on the development and expression of morphine tolerance and dependence in mice. Behav Pharm 14:121-127.
22. Hula NM, Marhitych VM, Hovseieva NM, Klimashevs'kyi VM, Zhukov OD, Synyts'kyi VM (1998) Brain lipid composition of the rat with experimental morphine dependence. Ukr Biokhim Zh 70:98-105.
23. Inturrisi CE (2002) Clinical pharmacology of opioids for pain. Clin J Pain 18:S3-S13.
24. Ivanov A, Aston-Jones G (2001) Local opiate withdrawal in locus coeruleus neurons in vitro. J Neurophysiol 85:2388-2397.
25. Kaminska B, Gaweda-Walerych K, Zawadzka M (2004) Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. J Cell Mol Med 8:45-58.
26. Kieffer BL, Gaveriaux-Ruff C (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66:285-306.
27. Kreek MJ (2001) Drug addictions. Molecular and cellular endpoints. Ann NY Acad Sci 937:27-49.
28. Lane-Ladd SB, Pineda J, Boundy VA, Pfeuffer T, Krupinski J, Aghajanian GK, Nestler EJ (1997) CREB (cAMP response element-binding protein) in the locus ceruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci 17:7890-7901.
29. McClung CA, Nestler EJ (2003) Regulation of gene expression and cocaine reward by CREB and ΔFosB. Nat Neurosci 6:1208-1215.
30. Nakai T, Hayashi M, Ichihara K, Wakabayashi H, Hoshi K (2002) Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2)-adrenoceptors. Pharmacol Res 45:407-412.
31. Narita M, Funada M, Suzuki T (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89:1-15.
32. Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278:58-63.
33. Nye HE, Nestler EJ (1996) Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 49:636-645.
34. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, Stromberg AJ (2003) Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4:26-34.
35. Punch L, Self DW, Nestler EJ, Taylor JR (1997) Opposite modulation of opiate withdrawal behaviors upon microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci 17:8520-8527.
36. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 10:2308-2317.
37. Rattan AK, Koo KL, Tejwani GA, Bhargava HN (1992) The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain Res 584:207-212.
38. Renshaw PF, Daniels S, Lundahl LH, Rogers V, Lukas SE (1999) Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report. Psychopharmacology 142:132-138.
39. Scammell JG, Denny WB, Valentine DL, Smith DF (2001) Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three new world primates. Gen Comp Endocrin 124:152-165.
40. Selevich MI, Lelevich VV (1997) Effect of chronic morphine administration on concentrations of individual lipids in various rat brain structures. Ukr Biokhim Zh 69:107-110.
41. Self DW, McClenahan AW, Beitner-Johnson D, Terwilliger RZ, Nestler EJ (1995) Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21:312-318.
42. Shaw-Lutchman TZ, Barrot M, Wallace T, Gilden L, Zachariou V, Impey S, Duman RS, Storm D, Nestler EJ (2002) Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci 22:3663-3672.
43. Shippenberg TS, Rea W (1997) Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol Biochem Behav 57:449-455.
44. Shippy R, Sendera TJ, Lockner R, Palaniappan C, Kaysser-Kranich T, Watts G, Alsobrook J (2004) Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. BMC Genomics 5:61-76.
45. Silveri MM, Pollack MH, Diaz CI, Nassar LE, Mendelson JH, Yurgelun-Todd DA, Renshaw PF, Kaufman MJ (2004) Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Res 131:217-226.
46. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A, Le Meur M, Roques BP, Maldonado R, Kieffer BL (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17:886-897.
47. Sinars C, Cheung-Flynn J, Rimerman RA, Scammell JG, Smith DF, Clardy J (2003) Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc Natl Acad Sci USA 100:868-873.
48. Taylor JR, Elsworth JD, Garcia EJ, Grant SJ, Roth RH, Redmond Jr DE (1988) Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology (Berl) 96:121-134.
49. Walters CL, Kuo YC, Blendy JA (2003) Differential distribution of CREB in the mesolimbic dopamine reward pathway. J Neurochem 87:1237-1244.
50. Widnell KL, Russell DS, Nestler EJ (1994) Regulation of expression of cAMP element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci USA 91:10947-10951.
51. Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, Wynick D, Langel U, Picciotto MR (2003a) The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc Natl Acad Sci USA 100:9028-9033.
52. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ (2003b) Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA 100:13656-13661.